CN Patent

CN102066372B — 含脲基的5，6元杂芳双环化合物作为激酶抑制剂

Assigned to Kong Jingxin · Expires 2014-09-17 · 12y expired

What this patent protects

本发明提供含脲基的5，6元双环杂芳基化合物I和II，以及使用其治疗由蛋白激酶引起的疾病，这些激酶包括VEGFR2，c-Met，PDGFRβ，c-Kit，CSF1R或EphA2。

USPTO Abstract

本发明提供含脲基的5，6元双环杂芳基化合物I和II，以及使用其治疗由蛋白激酶引起的疾病，这些激酶包括VEGFR2，c-Met，PDGFRβ，c-Kit，CSF1R或EphA2。

Drugs covered by this patent

Patent Metadata

Patent number
CN102066372B
Jurisdiction
CN
Classification
—
Expires
2014-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Kong Jingxin
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.